Highlights
NASDAQ: VCNX       Vaccinex Inc
Last Price Today's Change   Day's Range   Trading Volume
2.76   +0.19 (7.39%)  2.51 - 2.85  739,000

Overview

 
Avg Volume (4 weeks):484,094
4 Weeks Range:2.00 - 2.85
4 Weeks Price Volatility (%):
89.41%
52 Weeks Range:1.63 - 12.23
52 Weeks Price Volatility (%):
10.66%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company’s lead platform technologies include SEMA4D antibody platform and ActivMAb antibody discovery platform. Its lead product candidate VX15 is in clinical development for the treatment of NSCLC, osteosarcoma and Huntington’s disease and additional product candidates VX5 and VX25 are in earlier stages of development.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4141  5001  442  76 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AMC 4.42-0.29 
 BB 18.03-1.52 
 EXPR 4.15+0.26 
 NOK 4.85+0.31 
 SNDL 0.60-0.033 
 PLTR 36.23+1.77 
 CTRM 0.381-0.026 
 GME 76.79-19.94 
 AAPL 142.92-0.15 
 BNGO 12.58+1.27